Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1998-2-12
pubmed:abstractText
Sixty-one Burkholderia cepacia isolates from patients with cystic fibrosis (CF) and four plant isolates were screened for production of the siderophores salicylic acid (SA), pyochelin, cepabactin, and ornibactins and fingerprinted by a PCR-based randomly amplified polymorphic DNA (RAPD) method. Of the 24 RAPD types determined, 22 (92%) were associated with isolates that produced SA, 21 (87%) were associated with isolates that produced ornibactins, 15 (60%) were associated with isolates that produced pyochelin, and 3 (12%) were associated with isolates that produced cepabactin. Of the 24 RAPD types plus 2 phenotypic variants of types 1 and 9, 3 were associated with isolates that produced all four siderophores, 8 were associated with isolates that produced three siderophores, 12 were associated with isolates that produced two siderophores, and 3 were associated with isolates that produced only one siderophore. These results suggest that the numbers and types of siderophores produced by CF isolates of B. cepacia correlate with RAPD type and that SA and ornibactins are the most prevalent siderophores produced.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-1372361, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-2170442, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-2533244, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-2937804, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-2952030, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-3216778, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-7504066, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-7505294, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-7513755, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-7517765, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-7517953, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-7580051, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-7686239, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-7689374, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-8629607, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-8840786, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-8940422, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-8958242, http://linkedlifedata.com/resource/pubmed/commentcorrection/9453660-9038317
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0019-9567
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
874-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Siderophore production by cystic fibrosis isolates of Burkholderia cepacia.
pubmed:affiliation
Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Centre, Alberta, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't